The DOI matches its Crossref record; 188 of the 188 references it cites were found in a registry or an index.
Renal interstitial fibrosis: mechanisms and evaluation
Open accessAbstract
PURPOSE OF REVIEW: Tubulointerstitial injury in the kidney is complex, involving a number of independent and overlapping cellular and molecular pathways, with renal interstitial fibrosis and tubular atrophy (IFTA) as the final common pathway. Furthermore, there are multiple ways to assess IFTA. RECENT FINDINGS: Cells involved include tubular epithelial cells, fibroblasts, fibrocytes, myofibroblasts, monocyte/macrophages, and mast cells with complex and still incompletely characterized cell-molecular interactions. Molecular mediators involved are numerous and involve pathways such as transforming growth factor (TGF)-β, bone morphogenic protein (BMP), platelet-derived growth factor (PDGF), and hepatocyte growth factor (HGF). Recent genomic approaches have shed insight into some of these cellular and molecular pathways. Pathologic evaluation of IFTA is central in assessing the severity of chronic disease; however, there are a variety of methods used to assess IFTA. Most assessment of IFTA relies on pathologist assessment of special stains such as trichrome, Sirius Red, and collagen III immunohistochemistry. Visual pathologist assessment can be prone to intra and interobserver variability, but some methods employ computerized morphometery, without a clear consensus as to the best method. SUMMARY: IFTA results from on orchestration of cell types and molecular pathways. Opinions vary on the optimal qualitative and quantitative assessment of IFTA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Control of inositol 1,4,5-trisphosphate-induced Ca2+ release by cytosolic Ca2+
Bootman, M. D., Missiaen, L., Parys, J. B., De Smedt, H., & Casteels, R. (1995) · Biochemical Journal · doi:10.1042/bj3060445 · Cited by 5,120
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
A perivascular origin for mesenchymal stem cells in multiple human organs
Crisan, M., Yap, S., Casteilla, L., Chen, C.-W., Corselli, M., Park, T. S., Andriolo, G., Sun, B., Zheng, B., Zhang, L., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.07.003 · Cited by 3,991
Junqueira, L. C. U., Bignolas, G., & Brentani, R. R. (1979) · The Histochemical Journal · doi:10.1007/bf01002772 · Cited by 2,574
Biomarkers for epithelial-mesenchymal transitions
Zeisberg, M., & Neilson, E. G. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36183 · Cited by 2,299
Klinge, U., Park, J.-K., & Klosterhalfen, B. (2013) · Pathobiology · doi:10.1159/000348446 · Cited by 1,783
Fibrotic disease and the TH1/TH2 paradigm
Wynn, T. A. (2004) · Nature Reviews Immunology · doi:10.1038/nri1412 · Cited by 1,765
Fate Tracing Reveals the Pericyte and Not Epithelial Origin of Myofibroblasts in Kidney Fibrosis
Humphreys, B. D., Lin, S.-L., Kobayashi, A., Hudson, T. E., Nowlin, B. T., Bonventre, J. V., Valerius, M. T., McMahon, A. P., & Duffield, J. S. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090517 · Cited by 1,442
Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury
Yang, L., Besschetnova, T. Y., Brooks, C. R., Shah, J. V., & Bonventre, J. V. (2010) · Nature Medicine · doi:10.1038/nm.2144 · Cited by 1,333
Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability
Radisky, D. C., Levy, D. D., Littlepage, L. E., Liu, H., Nelson, C. M., Fata, J. E., Leake, D., Godden, E. L., Albertson, D. G., Angela Nieto, M., et al. (2005) · Nature · doi:10.1038/nature03688 · Cited by 1,284
Research works printed but not linked: 50
- Moreso, 1994, Kidney Int, 46, 1721, 10.1038/ki.1994.474 · doi:10.1038/ki.1994.474
- Pape, 2004, Pediatr Transplant, 8, 565, 10.1111/j.1399-3046.2004.00229.x · doi:10.1111/j.1399-3046.2004.00229.x
- Servais, 2007, Transplantation, 84, 1595, 10.1097/01.tp.0000295749.50525.bd · doi:10.1097/01.tp.0000295749.50525.bd
- Nicholson, 1996, Br J Surg, 83, 1082, 10.1002/bjs.1800830813 · doi:10.1002/bjs.1800830813
- Diaz Encarnacion, 2004, Am J Transplant, 4, 248, 10.1046/j.1600-6143.2003.00311.x · doi:10.1046/j.1600-6143.2003.00311.x
- Takeda, 2010, Hypertens Res, 33, 965, 10.1038/hr.2010.112 · doi:10.1038/hr.2010.112
- Narasimhan, 2010, J Pediatr Urol, 6, 560, 10.1016/j.jpurol.2010.01.002 · doi:10.1016/j.jpurol.2010.01.002
- Scruggs, 2011, Am J Pathol, 178, 1891, 10.1016/j.ajpath.2010.12.029 · doi:10.1016/j.ajpath.2010.12.029
- Wiwanitkit, 2011, BJU Int, 107, 1847, 10.1111/j.1464-410X.2011.10350.x · doi:10.1111/j.1464-410x.2011.10350.x
- Sharfuddin, 2011, Nephrology, 7, 189
- Sakairi, 2007, Kidney Int, 72, 307, 10.1038/sj.ki.5002277 · doi:10.1038/sj.ki.5002277
- Toblli, 2011, Kidney Blood Press Res, 34, 20, 10.1159/000320380 · doi:10.1159/000320380
- Higgins, 2007, J Clin Invest, 117, 3810
- Snelgrove, 2012, Am J Pathol, 180, 91, 10.1016/j.ajpath.2011.09.039 · doi:10.1016/j.ajpath.2011.09.039
- Scian, 2011, Transplantation, 91, 657, 10.1097/TP.0b013e3182094a5a · doi:10.1097/tp.0b013e3182094a5a
- Khan, 2010, Transplantation, 90, 630, 10.1097/TP.0b013e3181ea391e · doi:10.1097/tp.0b013e3181ea391e
- Fan, 2009, J Pharmacol Sci, 111, 82, 10.1254/jphs.09152FP · doi:10.1254/jphs.09152fp
- Li, 2010, Kidney Blood Press Res, 33, 240, 10.1159/000317102 · doi:10.1159/000317102
- Kim, 2009, Kidney Int, 75, 1031, 10.1038/ki.2009.1 · doi:10.1038/ki.2009.1
- Truong, 2011, Contrib Nephrol, 169, 311, 10.1159/000314578 · doi:10.1159/000314578
- Ozdemir, 2011, Transplant Proc, 43, 524, 10.1016/j.transproceed.2011.01.080 · doi:10.1016/j.transproceed.2011.01.080
- Ortiz, 2010, Nephrol Dial Transplant, 25, 3492, 10.1093/ndt/gfq518 · doi:10.1093/ndt/gfq518
- Leask, 2010, ignal, 4, 197
- Zeisberg, 2006, Nephrol Dial Transplant, 21, 568, 10.1093/ndt/gfk010 · doi:10.1093/ndt/gfk010
- De Heer, 2000, Nephrol Dial Transplant, 15, 72, 10.1093/ndt/15.suppl_6.72 · doi:10.1093/ndt/15.suppl_6.72
- Okada, 2011, J Am Soc Nephrol, 22, 588, 10.1681/ASN.2011020131 · doi:10.1681/asn.2011020131
- Yan, 2010, Transpl Immunol, 23, 1, 10.1016/j.trim.2010.04.001 · doi:10.1016/j.trim.2010.04.001
- Grimm, 1999, Pediatric Transplant, 3, 257, 10.1034/j.1399-3046.1999.00044.x · doi:10.1034/j.1399-3046.1999.00044.x
- Choi, 2005, Am J Transplant, 5, 1354, 10.1111/j.1600-6143.2005.00830.x · doi:10.1111/j.1600-6143.2005.00830.x
- Cosio, 2005, Am J Transplant, 5, 2464, 10.1111/j.1600-6143.2005.01050.x · doi:10.1111/j.1600-6143.2005.01050.x
- Kostadinova-Kunovska, 2005, Prilozi, 26, 51
- Servais, 2009, Am J Transplant, 9, 2552, 10.1111/j.1600-6143.2009.02803.x · doi:10.1111/j.1600-6143.2009.02803.x
- Vleming, 1995, Clin Nephrol, 44, 211
- Abrass, 1999, Am J Kidney Dis, 33, 11, 10.1016/S0272-6386(99)70252-0 · doi:10.1016/s0272-6386(99)70252-0
- Verkade, 1999, J Am Soc Nephrol, 10, 584
- Sund, 2004, Nephrol Dial Transplant, 19, 2838, 10.1093/ndt/gfh490 · doi:10.1093/ndt/gfh490
- Bains, 2005, Br J Surg, 92, 113, 10.1002/bjs.4777 · doi:10.1002/bjs.4777
- Hunter, 2005, Kidney Int, 67, 94, 10.1111/j.1523-1755.2005.00059.x · doi:10.1111/j.1523-1755.2005.00059.x
- Masseroli, 1998, Lab Invest, 78, 511
- Ruiz, 1988, Transplantation, 45, 91, 10.1097/00007890-198801000-00021 · doi:10.1097/00007890-198801000-00021
- Ruiz, 1988, Transplant Proc, 20, 807
- Liu, 2006, nt, 70, 238
- Vilayur, 2009, ephrol, 5, 375
- Marcussen, 1995, Transplantation, 60, 1083, 10.1097/00007890-199511270-00004 · doi:10.1097/00007890-199511270-00004
- Feldman, 2000, J Cardiovasc Pharmacol, 36, S255, 10.1097/00005344-200036051-00075 · doi:10.1097/00005344-200036051-00075
- Satoh, 2001, J Am Soc Nephrol, 12, 317, 10.1681/ASN.V122317 · doi:10.1681/asn.v122317
- Meas-Yedid, 2011, Transplantation, 92, 890, 10.1097/TP.0b013e31822d879a · doi:10.1097/tp.0b013e31822d879a
- Servais, 2011, Am J Transplant, 11, 1456, 10.1111/j.1600-6143.2011.03594.x · DOI
- Shishido, 2003, J Am Soc Nephrol, 14, 1046, 10.1097/01.ASN.0000056189.02819.32 · doi:10.1097/01.asn.0000056189.02819.32
- Fogo, 2011, ephrol, 22, 11
Cited by
Ju, W., Nair, V., Smith, S., Zhu, L., Shedden, K., Song, P. X. K., Mariani, L. H., Eichinger, F. H., Berthier, C. C., Randolph, A., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac7071 · Cited by 426
Extracellular Matrix in Kidney Fibrosis: More Than Just a Scaffold
Bülow, R. D., & Boor, P. (2019) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155419849388 · Cited by 406
The utility of iron chelators in the management of inflammatory disorders
Lehmann, C., Islam, S., Jarosch, S., Zhou, J., Hoskin, D., Greenshields, A., Al-Banna, N., Sharawy, N., Sczcesniak, A., Kelly, M., et al. (2015) · Mediators of Inflammation · doi:10.1155/2015/516740 · Cited by 54
“Renal interstitial fibrosis is characterized by the accumulation of collagen and related molecules in the interstitium, involving cells like tubular epithelial cells, fibroblasts, fibrocytes, myofibroblasts, monocyte/macrophages, andmast cells [79], and can be caused inter alia by inflammatory processes [80].”
BackgroundLiu, J.-H., He, L., Zou, Z.-M., Ding, Z.-C., Zhang, X., Wang, H., Zhou, P., Xie, L., Xing, S., & Yi, C.-Z. (2018) · Kidney and Blood Pressure Research · doi:10.1159/000494745 · Cited by 32
Nageeb, M. M., Talaat, A., Reda, S. M., & Elsammak, G. A. (2024) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-023-02585-4 · Cited by 7
Metadata
- Authors
- Farris, A. B., & Colvin, R. B.
- Venue
- Current Opinion in Nephrology and Hypertension
- Published
- 2012-05
- Volume
- 21
- Issue
- 3
- Pages
- 289-300
- ISSN
- 1062-4821 (ISSN-L)
- OpenAlex
- W19843932
- Cited by
- 298
- References
- 188
- FWCI
- 16.25
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Renal interstitial fibrosis: mechanisms and evaluation. https://app.cochat.ai/papers/10.1097/mnh.0b013e3283521cfa
- The paper
- Farris, A. B., & Colvin, R. B. (2012). Renal interstitial fibrosis: mechanisms and evaluation. Current Opinion in Nephrology and Hypertension. https://doi.org/10.1097/mnh.0b013e3283521cfa
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.